SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095421
Filing Date
2024-08-12
Accepted
2024-08-12 16:10:21
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bold-20240630.htm   iXBRL 10-Q 1608924
2 EX-10.1 bold-ex10_1.htm EX-10.1 33384
3 EX-31.1 bold-ex31_1.htm EX-31.1 14677
4 EX-31.2 bold-ex31_2.htm EX-31.2 14657
5 EX-32.1 bold-ex32_1.htm EX-32.1 12832
  Complete submission text file 0000950170-24-095421.txt   6581660

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bold-20240630.xsd EX-101.SCH 895506
65 EXTRACTED XBRL INSTANCE DOCUMENT bold-20240630_htm.xml XML 1105223
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

IRS No.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41989 | Film No.: 241196859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)